Effects of different doses of cisatracurium on nerve monitoring in thyroid surgery

Effects of different doses of cisatracurium on intraoperative laryngeal nerve monitoring in patients with thyroid surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023627

Enrollment

Unknown

Registered

2019-06-04

Start date

2019-06-30

Completion date

Unknown

Last updated

2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid disease

Interventions

Three Groups:different doses of cis-atracurium.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years, and the ASA I-II; 2. patient with thyroid disease, requiring thyroid surgery; 3. Be able to understand and voluntarily sign the informed consent form; 4. Be able to follow the research requirements and cooperate with the researcher's visit time.

Exclusion criteria

Exclusion criteria: 1. Hoarseness before surgery; 2. Malignant tumors, severe cardiovascular and cerebrovascular diseases, poor general condition; 3. Patients with neurological and endocrine diseases; 4. Patients with small mandibular or facial deformities and a history of difficult airway disease; 5. With active infections; 6. With a history of drug abuse; 7. Difficult on communication, unable to describe who's own symptoms; 8. Currently participating in another clinical study; 9. Any experimental drug (product not approved by a health agency) is currently in use.

Design outcomes

Primary

Measure	Time frame
Tracheal intubation condition score;	—

Countries

China

Contacts

Public ContactCheng Li

Shanghai Tenth People's Hospital

marklisa@163.com+86 15121081239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026